Rafferty Asset Management
ATRA icon

Rafferty Asset Management’s Atara Biotherapeutics ATRA Stock Holding History

Rafferty Asset Management’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-28,410
Closed -$2.06M – 1096
2023
Q1 		$2.06M Buy
28,410
+2,419
+9% +$235K 0.01% 605
2022
Q4 		$2.13M Sell
25,991
-960
-4% -$100K 0.02% 556
2022
Q3 		$2.55M Buy
26,951
+11,434
+74% +$1.28M 0.03% 456
2022
Q2 		$3.02M Buy
15,517
+34
+0.2% +$5.55K 0.03% 386
2022
Q1 		$3.6M Buy
15,483
+5,366
+53% +$1.71M 0.02% 459
2021
Q4 		$3.99M Buy
10,117
+5,208
+106% +$2.19M 0.02% 464
2021
Q3 		$2.2M Sell
4,909
-1,415
-22% -$507K 0.02% 614
2021
Q2 		$2.46M Sell
6,324
-1,561
-20% -$557K 0.02% 614
2021
Q1 		$2.83M Buy
7,885
+7,023
+815% +$3.1M 0.02% 527
2020
Q4 		$423K Sell
862
-1,991
-70% -$919K ﹤0.01% 719
2020
Q3 		$924K Buy
2,853
+1,408
+97% +$479K 0.01% 587
2020
Q2 		$526K Buy
+1,445
New +$365K 0.01% 700
2020
Q1 		– Sell
-2,528
Closed -$1.04M – 615
2019
Q4 		$1.04M Sell
2,528
-3,977
-61% -$1.37M 0.02% 542
2019
Q3 		$2.3M Buy
6,505
+1,725
+36% +$644K 0.04% 312
2019
Q2 		$2.4M Buy
4,780
+2,184
+84% +$1.54M 0.04% 317
2019
Q1 		$2.58M Buy
+2,596
New +$2.41M 0.04% 275

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Rafferty Asset Management's ATRA Position: Q2 2023 in Review

Rafferty Asset Management sold out of Atara Biotherapeutics (ATRA) in Q2 2023, closing a stake of 28,410 shares — an estimated $2.06M sold.

Rafferty Asset Management first reported a position in ATRA in Q1 2019 and held it in 16 quarters. The position peaked at $3.99M in Q4 2021. 118 funds tracked by Wall St. Rank hold ATRA as of Q2 2023.

  • Rafferty Asset Management reported no remaining Atara Biotherapeutics position as of Q2 2023 after selling out during the quarter.
  • Rafferty Asset Management sold 28,410 Atara Biotherapeutics shares in Q2 2023, an estimated $2.06M.
  • Rafferty Asset Management first reported a position in Atara Biotherapeutics in Q1 2019 and held it in 16 quarters.
  • Rafferty Asset Management's Atara Biotherapeutics position peaked at $3.99M in Q4 2021.
  • 118 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q2 2023.

Based on Rafferty Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.